GSP Crop Science Ltd Q2 Revenue Rises 19.5%, Profit Falls 23.7%

GSP Crop Science Limited reported consolidated revenue of ₹558.42 crore for Q2 FY27, up 19.5% year on year, while consolidated net profit declined 23.7% to ₹44.64 crore. The result shows stronger reported revenue during the July-September quarter but a lower profit outcome despite an operating margin of 11.4%.

What did GSP Crop Science report for Q2 FY27?

GSP Crop Science reported consolidated revenue from operations of ₹558.42 crore and consolidated net profit of ₹44.64 crore for the quarter ended September 30, 2026. Revenue increased 19.5% from the corresponding quarter of the previous year, while net profit decreased 23.7% year on year.

The company reported an operating margin of 11.4% on a consolidated basis. The filing did not provide a detailed break-up of the factors behind the year-on-year movement in profitability. Therefore, the disclosed figures establish higher revenue and lower net profit, without supporting a specific explanation for the profit decline.

On a standalone basis, GSP Crop Science recorded revenue of ₹599.25 crore and net profit of ₹44.23 crore. Its standalone operating margin was 9.8%. The standalone and consolidated disclosures are presented separately in the results and should be assessed as distinct reported measures.

How did the Q2 result compare with the previous quarter?

GSP Crop Science had reported revenue of ₹386 crore and profit of ₹26.0 crore for the April-June 2026 quarter, or Q1 FY27. Q1 revenue was up 2.4% year on year from ₹377 crore, while profit rose 13.0% from ₹23.0 crore.

Compared with those disclosed Q1 figures, the Q2 consolidated result contains higher absolute revenue and profit. However, the company reported Q1 figures in the supplied information without specifying whether every metric was on the same standalone or consolidated basis. Direct quarter-to-quarter comparisons should consequently be treated with care.

Before the Q2 filing, market expectations mentioned revenue of about ₹380 crore to ₹410 crore and profit in the mid-₹20 crore range. The reported consolidated revenue of ₹558.42 crore and profit of ₹44.64 crore are above those cited pre-result ranges. These estimates were not company guidance and should not be treated as management targets.

What was decided at the board meeting?

GSP Crop Science's Board of Directors was scheduled to consider and approve the unaudited standalone and consolidated financial results for Q2 and the half-year ended September 30, 2026, at its November 13, 2026 meeting. The reported Q2 figures relate to the July-September 2026 period.

The board also appointed Shail Jayesh Shah as chief financial officer. The appointment follows references in the supplied material to a CFO transition, making the finance leadership change relevant alongside the results announcement.

The limited-review reports carried no qualifications. This means the review reports cited in the filing did not record qualified conclusions. It is a disclosure point for investors assessing the reporting process, although it does not itself explain the revenue or profit movement.

What does the result mean for investors and operations?

GSP Crop Science's Q2 result presents two different operating signals: consolidated revenue grew 19.5% year on year, but consolidated net profit fell 23.7%. Investors assessing the quarter will therefore focus on whether the revenue increase can be sustained and whether operating profitability can improve from the reported level.

The difference between the 11.4% consolidated operating margin and the 9.8% standalone margin also makes both sets of statements relevant. Consolidated results include the reporting group, while standalone figures relate to the parent entity. The company has not provided sufficient detail in the supplied data to attribute the difference to any particular business, geography, product group, or subsidiary.

GSP Crop Science operates in the manufacture and sale of agrochemicals in India and international markets. The reported Q2 outcome is relevant to shareholders because it follows a Q1 period in which revenue was broadly steady year on year and profit rose, based on the figures disclosed for the quarter ended June 2026.

What should investors watch after the Q2 FY27 filing?

GSP Crop Science has scheduled an earnings conference call for November 16, 2026, at 11:00 AM IST to discuss Q2 and H1 FY27 operational and financial performance. The call gives analysts and shareholders an opportunity to seek further context on the reported revenue increase, lower year-on-year consolidated profit, and operating margins.

Management had earlier indicated a plan for about 15% revenue growth and 13% to 14% operating profit growth during FY27 and over the following two to three years. The supplied material said revenue was on track, while operating profit growth was not separately reaffirmed. Any clarification on this point will be relevant because Q2 net profit was lower year on year.

The company had also received a SEBI Regulation 74(5) certificate from its registrar and share transfer agent, MUFG Intime India Private Limited, for the quarter ended September 30, 2026. The certificate confirmed dematerialised-securities processing disclosures and is separate from the financial results.

Conclusion

GSP Crop Science delivered 19.5% year-on-year consolidated revenue growth in Q2 FY27 to ₹558.42 crore, but its consolidated net profit fell 23.7% to ₹44.64 crore. The quarter combines stronger reported sales with lower profitability, while the 11.4% consolidated operating margin and unqualified limited-review reports provide additional context to the filing.

The next disclosed event is the November 16, 2026 earnings call on Q2 and H1 FY27 performance. Investors will watch for management's explanation of the profit decline, comments on the CFO appointment, and any update on the previously indicated FY27 revenue and operating-profit growth plans.